120 related articles for article (PubMed ID: 38940205)
1. Electrochemical profiling of poliovirus particles inactivated by chemical method and ionizing radiation.
Agafonova LE; Shumyantseva VV; Ivin YY; Piniaeva AN; Kovpak AA; Ishmukhametov AA; Budnik SV; Churyukin RS; Zhdanov DD; Archakov AI
Biomed Khim; 2024 Jun; 70(3):161-167. PubMed ID: 38940205
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the reduction in potential health risks by determining the sensitivity of poliovirus type 1 chat strain and rotavirus SA-11 to electron beam irradiation of iceberg lettuce and spinach.
Espinosa AC; Jesudhasan P; Arredondo R; Cepeda M; Mazari-Hiriart M; Mena KD; Pillai SD
Appl Environ Microbiol; 2012 Feb; 78(4):988-93. PubMed ID: 22179244
[TBL] [Abstract][Full Text] [Related]
3. Investigation of a predicted N-terminal amphipathic α-helix using atomistic molecular dynamics simulation of a complete prototype poliovirus virion.
Roberts JA; Kuiper MJ; Thorley BR; Smooker PM; Hung A
J Mol Graph Model; 2012 Sep; 38():165-73. PubMed ID: 23085162
[TBL] [Abstract][Full Text] [Related]
4. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.
Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F
Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849
[TBL] [Abstract][Full Text] [Related]
5. Identification and Characterization of a Poliovirus Capsid Mutant with Enhanced Thermal Stability.
Nguyen Y; Jesudhasan PR; Aguilera ER; Pfeiffer JK
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567995
[TBL] [Abstract][Full Text] [Related]
6. Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection.
Adeyemi OO; Nicol C; Stonehouse NJ; Rowlands DJ
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928008
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating.
Pelletier I; Ouzilou L; Arita M; Nomoto A; Colbère-Garapin F
Virology; 2003 Jan; 305(1):55-65. PubMed ID: 12504541
[TBL] [Abstract][Full Text] [Related]
8. Effect of formaldehyde inactivation on poliovirus.
Wilton T; Dunn G; Eastwood D; Minor PD; Martin J
J Virol; 2014 Oct; 88(20):11955-64. PubMed ID: 25100844
[TBL] [Abstract][Full Text] [Related]
9. Perspectives for the creation of a new type of vaccine preparations based on pseudovirus particles using polio vaccine as an example.
Zhdanov DD; Ivin YY; Shishparenok AN; Kraevskiy SV; Kanashenko SL; Agafonova LE; Shumyantseva VV; Gnedenko OV; Pinyaeva AN; Kovpak AA; Ishmukhametov AA; Archakov AI
Biomed Khim; 2023 Nov; 69(5):253-280. PubMed ID: 37937429
[TBL] [Abstract][Full Text] [Related]
10. Structure of the Fab-labeled "breathing" state of native poliovirus.
Lin J; Lee LY; Roivainen M; Filman DJ; Hogle JM; Belnap DM
J Virol; 2012 May; 86(10):5959-62. PubMed ID: 22398295
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of poliovirus inactivation by the direct and indirect effects of ionizing radiation.
Ward RL
Radiat Res; 1980 Aug; 83(2):330-44. PubMed ID: 6250187
[No Abstract] [Full Text] [Related]
12. Use of a Glycan Library Reveals a New Model for Enteric Virus Oligosaccharide Binding and Virion Stabilization.
Lu H; Lehrman MA; Pfeiffer JK
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852778
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of poliovirus by gamma irradiation of wastewater sludges.
Kaupert N; Burgi E; Scolaro L
Rev Argent Microbiol; 1999; 31(1):49-52. PubMed ID: 10327461
[TBL] [Abstract][Full Text] [Related]
14. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
[TBL] [Abstract][Full Text] [Related]
15. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes.
Bubeck D; Filman DJ; Cheng N; Steven AC; Hogle JM; Belnap DM
J Virol; 2005 Jun; 79(12):7745-55. PubMed ID: 15919927
[TBL] [Abstract][Full Text] [Related]
16. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
Ketterlinus R; Wiegers K
Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
Blomqvist S; Bruu AL; Stenvik M; Hovi T
J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
[TBL] [Abstract][Full Text] [Related]
18. An externalized polypeptide partitions between two distinct sites on genome-released poliovirus particles.
Lin J; Cheng N; Chow M; Filman DJ; Steven AC; Hogle JM; Belnap DM
J Virol; 2011 Oct; 85(19):9974-83. PubMed ID: 21775460
[TBL] [Abstract][Full Text] [Related]
19. Conformational shift of a major poliovirus antigen confirmed by immuno-cryogenic electron microscopy.
Lin J; Cheng N; Hogle JM; Steven AC; Belnap DM
J Immunol; 2013 Jul; 191(2):884-91. PubMed ID: 23772035
[TBL] [Abstract][Full Text] [Related]
20. The effect of anionic surfactant on poliovirus particles during capillary electrophoresis.
Oita I; Halewyck H; Thys B; Rombaut B; Heyden YV
J Pharm Biomed Anal; 2012 Dec; 71():79-88. PubMed ID: 22906690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
